Gates’ GMO Mosquitoes as “Flying Syringes” to Vaccinate All! Test in Seattle with Human Guinea-Pigs after Italian Study
by Fabio Giuseppe Carlo Carisio
“We use the mosquitoes like they’re 1,000 small flying syringes,” explains University of Washington, Seattle physician and scientist Dr. Sean Murphy, lead author on a paper in Science Translational Medicine released on August 24 detailing the vaccine trials (all links to the original sources cited at the bottom of the page).
The insects deliver live malaria-causing Plasmodium parasites that have been genetically modified to not get people sick. The body still makes antibodies against the weakened parasite so it’s prepared to fight the real thing.
The author made it a point to state: “To be clear, Murphy’s not planning to use mosquitoes to vaccinate millions of people.”Do you believe him? And even if Dr. Murphy himself is not planning on using the technology to mass-vaccinate people, what is to stop others from doing so?
Bill Gates, for example, has already spent $BILLIONS on developing a malaria vaccine over the past decade, and last year he funded a biotech firm that released genetically modified mosquitoes in the Florida Keys.
And it has also financed important experiments in Italy, conducted in Terni (Umbria) by zoologist Andrea Crisanti, recently elected to the Senate of the Italian Republic in the ranks of the Democratic Party which has imposed mandatory anti-Covid vaccines on many professional categories and the over 50s.
https://www.gospanews.net/2022/08/24/il-pd-lancia-crisanti-scienziato-delle-zanzare-ogm-di-gates-responsabile-del-progetto-target-malaria-a-terni/
The suspicion is therefore not only legitimate but also disturbing …
The alarm was raised by the Health Impact News website which described in great detail the reactions of “human guinea pigs”. This is not a science fiction speculation but a real transhumanist experiment conducted by some of the most important American researchers. It is a research published in Science and therefore cannot be considered a “hoax”.
Precisely for this reason, at the end of this short introduction we will publish the Abstract of the study and the names of the scientists who are conducting it.
But Gospa News has discovered even more alarming intrigues!
Today the technique of spreading vaccines through genetically modified mosquitoes is being tested against Malaria, which is in decline in Asian and African countries, tomorrow it could be used against Covid-19 (assuming that it has not already been used to spread the virus like some intelligence sources have argued) or Monkeypox. Who can rule it out?
GATES & FAUCI BEHIND THE ANTI-MALARIA VACCINE
«A recent clinical study showed a favorable safety profile with no breakthrough to blood stage infection when PfGAP3KO was administered to human subjects by the bites of approximately 200 PfGAP3KO-infected mosquitoes»
This is what was published in a 2017 research entitled “Genetically attenuated malaria parasites as vaccines” which immediately reveals who the sponsors of the new miraculous vaccine are: the usual Gates and Fauci !.
In fact, the declaration of interest reads:
«A M Vaughan has received grants from the NIH. S H I Kappe has received grants from the NIH, Bill and Melinda Gates Foundation, the Department of Defense and is an inventor listed on U.S. Patents pertaining to GAP technology. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed».
GAP is a biogenetic acronym which means “genetically attenuated parasites”.
In a subsequent 2018 study on the same vaccine entitled “Malaria Vaccines: Recent Advances and New Horizons” among the sponsors are the usual suspects:
«S.J.D. is a Jenner Investigator, a Lister Institute Research Prize Fellow, a Wellcome Trust Senior Fellow (grant number 106917/Z/15/Z). C.M.N. is a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellow (209200/Z/17/Z). M.K.H. is a Wellcome Trust Senior Investigator (101020/Z/13/Z). C.R.K. is Director of R&D at PATH’s Malaria Vaccine Initiative. This work was supported in part by the Intramural Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases».
Wellcome Trust, it should be remembered, is one of the NGOs created by Gates that has been accused of lobbying US and EU governments and officials on emergency anti-Covid policies that have resulted in massive purchases of Pfizer and Moderna’s dangerous gene serums.
The lead researcher of the 2018 study is Simon J. Draper (SJD) working for The Jenner Institute, University of Oxford, Old Road Campus Research Building. Could it be a coincidence that it is the institute that developed the AstraZeneca anti-Covid vaccine in the United Kingdom, which proved to be as cheap as lethal in some cases recognized by doctors?
And are we to believe that they have no interest after they have been playing on the laboratory coronaviruses that caused the Covid-19 pandemic since 2000?
THE REACTIONS AFTER THE TREATMENT
Here are the disconcerting testimonies of those undergoing the treatment.
One Seattle morning, Carolina Reid sat in a room with nine other volunteers, each waiting to take part in a clinical trial for a new, experimental malaria vaccine.
Reid’s turn came. She put her arm over a cardboard box filled with 200 mosquitoes and covered with a mesh that keeps them in but still lets them bite. “Literally a Chinese food takeout container” is how she remembers it. A scientist then covered her arm with a black cloth, because mosquitoes like to bite at night.
Then the feeding frenzy began.
“My whole forearm swelled and blistered,” says Reid. “My family was laughing, asking like, ‘why are you subjecting yourself to this?’” And she didn’t just do it once. She did it five times.
Carolina Reid, who was paid $4,100 to participate in the study, tested positive for malaria and was not able to finish the study.
But that reportedly did not dampen her enthusiasm: “I actually cried when they told me I had malaria because I developed such a close relationship with the nurses,” Reid says. She wanted to continue through the trials, but her infection made her ineligible. She was given a drug to clear her case of malaria and sent home.
Her experience was so positive that she went on to participate in clinical trials for a bird flu vaccine and the Moderna COVID-19 vaccine. She says that she will continue to enroll in vaccine clinical trials “for the rest of my life actually.”
It should be remembered that Moderna’s messenger RNA-based gene serum, funded by Bill Gates as well as the Pentagon’s military agency DARPA, was patented nine months before the pandemic’s outbreak from the SARS-Cov-2 which has 19 nucleotides identical to those of a human gene built in the laboratory by Big Pharma of Cambridge (Massachusetts), also supported by Anthony Fauci, director of the American body for infectious diseases NIAID (National Institute of Allergy and Infectious Diseases).
By a curious coincidence one of the researchers on the vaccine to be inoculated by mosquitoes is Gregory A. Deye who works in the NIAD…
Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization
follow Gospa News on Telegram
SCIENCE – A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infectionTHE HEALTH IMPACT NEWS NIH – Malaria Vaccines: Recent Advances and New HorizonsTAYLOR & FRANCIS ONLINE – Genetically attenuated malaria parasites as vaccines
THE STUDY PUBLISHED BY SCIENCE TRANLATION MEDICINE
All links to Gospa News articles have been added aftermath
Malaria vaccine advance
Genetically attenuated malaria parasite vaccines are currently being developed as candidates for protection against Plasmodium falciparum infection. Murphy et al.used a genetically attenuated P. falciparum sporozoite vaccine they had previously developed that has deletions in parasite genes P52, P36, and SAP1 (PfGAP3KO) to evaluate protection against controlled human malaria infection (CHMI).
Vaccine was administered three or five times by ~200 PfGAP3KO-infected mosquito bites per immunization and did not cause any breakthrough infections. CHMI challenge was carried out 1 month after final immunization via P. falciparum–infected mosquito bites. Half of the individuals in each vaccine group did not develop detectable P. falciparum infection, and a subset of these individuals was subjected to a second CHMI 6 months later and remained partially protected. These results support further development of genetically attenuated sporozoites as potential malaria vaccines.
Abstract
Genetically engineered live Plasmodium falciparum sporozoites constitute a potential platform for creating consistently attenuated, genetically defined, whole-parasite vaccines against malaria through targeted gene deletions. Such genetically attenuated parasites (GAPs) do not require attenuation by irradiation or concomitant drug treatment. We previously developed a P. falciparum (Pf) GAP with deletions in P52, P36, and SAP1 genes (PfGAP3KO) and demonstrated its safety and immunogenicity in humans. Here, we further assessed safety, tolerability, and immunogenicity of the PfGAP3KO vaccine and tested its efficacy against controlled human malaria infection (CHMI) in malaria-naïve subjects.
The vaccine was delivered by three (n = 6) or five (n = 8) immunizations with ~200 PfGAP3KO-infected mosquito bites per immunization. PfGAP3KO was safe and well tolerated with no breakthrough P. falciparum blood stage infections. Vaccine-related adverse events were predominately localized urticaria related to the numerous mosquito bites administered per vaccination. CHMI via bites with mosquitoes carrying fully infectious Pf NF54 parasites was carried out 1 month after the last immunization. H
alf of the study participants who received either three or five PfGAP3KO immunizations remained P. falciparum blood stage negative, as shown by a lack of detection of Plasmodium 18S rRNA in the blood for 28 days after CHMI. Six protected study participants received a second CHMI 6 months later, and one remained completely protected. Thus, the PfGAP3KO vaccine was safe and immunogenic and was capable of inducing protection against sporozoite infection. These results warrant further evaluation of PfGAP3KO vaccine efficacy in dose-range finding trials with an injectable formulation.
THE SCIENTISTS AUTHORS OF THE EXPERIMENTATION
Sean C. Murphy† https://orcid.org/0000-0002-2048-0131
Department of Laboratory Medicine and Pathology and Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA. Department of Microbiology, University of Washington, Seattle, WA 98109, USA.
Roles: Conceptualization, Investigation, Methodology, Resources, Visualization, Writing – original draft, and Writing – review & editing.
Ashley M. Vaughan† https://orcid.org/0000-0001-5815-756X
Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA 98109, USA. Department of Pediatrics, University of Washington, Seattle, WA 98105, USA.
Roles: Conceptualization, Data curation, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, and Writing – review & editing.
James G. Kublin https://orcid.org/0000-0003-1279-3741
Department of Global Health, University of Washington, Seattle, WA 98195, USA. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Roles: Conceptualization, Methodology, Supervision, and Writing – review & editing.
Matthew Fishbauger
Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA 98109, USA.
Roles: Investigation and Resources.
Gregory A. Deye https://orcid.org/0000-0001-5527-4541
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD, USA.
Roles: Conceptualization, Funding acquisition, Methodology, Project administration, and Writing – review & editing.
Jessica Butts https://orcid.org/0000-0002-3598-5861
Emmes Company, Rockville, MD, USA.
Roles: Data curation, Formal analysis, Software, Validation, and Visualization.
Un pensiero su “Gates’ GMO Mosquitoes as “Flying Syringes” to Vaccinate All! Test in Seattle with Human Guinea-Pigs after Italian Study”